| Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter (NCT00066352) | University Health Network, Toronto | 2003-09-01 |
| Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor (NCT01684098) | Endocyte | 2003-08-01 |
| S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy (NCT00066612) | SWOG Cancer Research Network | 2003-07-01 |
| Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT (NCT00246974) | AstraZeneca | 2003-05-01 |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant (NCT00082706) | M.D. Anderson Cancer Center | 2003-04-23 |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors (NCT00471432) | NCIC Clinical Trials Group | 2003-04-04 |
| S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium (NCT00045630) | SWOG Cancer Research Network | 2003-01-01 |
| Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer (NCT00055601) | Radiation Therapy Oncology Group | 2002-12-01 |
| S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium (NCT00055835) | SWOG Cancer Research Network | 2002-11-01 |
| Tipifarnib in Treating Patients With Recurrent Bladder Cancer (NCT00047216) | University Health Network, Toronto | 2002-11-01 |
| Cost-Effectiveness in Bladder Cancer (NCT00126958) | Erasmus Medical Center | 2002-07-01 |
| Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer (NCT00042887) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-05-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| The New England Bladder Cancer Study (NCT00342875) | National Cancer Institute (NCI) | 2002-03-01 |
| A Comparison of the Studer Pouch Versus the T-Pouch Orthotopic Neobladder Urinary Diversion in Bladder Cancer Patients (NCT01008865) | University of Southern California | 2002-01-04 |
| Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer (NCT00089128) | Medical University of South Carolina | 2001-11-01 |
| Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer (NCT00028860) | Tulane University Health Sciences Center | 2001-10-01 |
| Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer (NCT00052637) | Photocure | 2001-09-01 |
| Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer (NCT00054626) | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | 2001-09-01 |
| Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium (NCT00080795) | M.D. Anderson Cancer Center | 2001-07-01 |
| S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract (NCT00022633) | SWOG Cancer Research Network | 2001-07-01 |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00024349) | University Hospital Birmingham | 2001-06-01 |
| BCG With or Without Mitomycin in Treating Patients With Bladder Cancer (NCT00023842) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-06-01 |
| Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer (NCT00022191) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function (NCT00005644) | Eastern Cooperative Oncology Group | 2001-01-02 |
| Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium (NCT00014274) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-01-01 |
| Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment (NCT00016237) | EMD Serono | 2000-12-01 |
| Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer (NCT00033436) | Mount Vernon Cancer Centre at Mount Vernon Hospital | 2000-10-01 |
| Suramin in Treating Patients With Recurrent Bladder Cancer (NCT00006476) | Cancer Research UK | 2000-10-01 |
| Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer (NCT00014287) | University of Pittsburgh | 2000-09-01 |
| Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer (NCT00146276) | Association of Urologic Oncology (AUO) | 2000-07-01 |
| Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer (NCT00006105) | University of Chicago | 2000-06-01 |
| SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00006351) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-06-01 |
| Prognostic Biomarkers in Patients With Urothelial Carcinoma (NCT04872036) | Hellenic Cooperative Oncology Group | 2000-05-01 |
| Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract (NCT00006026) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-05-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer (NCT00005858) | University of Maryland, Baltimore | 2000-04-01 |
| Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients (NCT00579514) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| R115777 in Treating Patients With Advanced Bladder Cancer (NCT00006376) | H. Lee Moffitt Cancer Center and Research Institute | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Oxaliplatin in Treating Patients With Metastatic Bladder Cancer (NCT00004203) | University of Chicago | 2000-02-01 |
| Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder (NCT00136175) | University of Michigan Rogel Cancer Center | 1999-11-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer (NCT00005958) | Amgen | 1999-10-01 |
| High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer (NCT00003623) | Alliance for Clinical Trials in Oncology | 1999-10-01 |
| Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00003930) | Radiation Therapy Oncology Group | 1999-09-01 |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00004095) | Northwestern University | 1999-08-01 |
| Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer (NCT00005086) | University of Chicago | 1999-08-01 |
| Evaluation for NCI Surgery Branch Clinical Research Protocols (NCT00001823) | National Cancer Institute (NCI) | 1999-07-11 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer (NCT00006118) | GERCOR - Multidisciplinary Oncology Cooperative Group | 1999-07-01 |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer (NCT00004122) | Roswell Park Cancer Institute | 1999-07-01 |
| Combination Chemotherapy in Treating Patients With Bladder Cancer (NCT00003701) | Eastern Cooperative Oncology Group | 1999-04-02 |
| S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer (NCT00003824) | SWOG Cancer Research Network | 1999-04-01 |
| Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract (NCT00006111) | UNICANCER | 1999-04-01 |
| Eflornithine in Treating Patients With Bladder Cancer (NCT00003814) | National Cancer Institute (NCI) | 1999-02-01 |
| Endoscopic Subsurface Optical Imaging for Cancer Detection (NCT01810445) | University of California, Davis | 1999-01-01 |
| Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium (NCT00003376) | Eastern Cooperative Oncology Group | 1998-12-03 |
| AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer (NCT00003759) | Anthra Pharmaceuticals | 1998-11-01 |
| Biological Therapy in Treating Patients With Bladder Cancer (NCT00003779) | Swiss Cancer Institute | 1998-11-01 |
| Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00003642) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-10-01 |
| Interdisciplinary Case-Control Study of Bladder Cancer in Spain (NCT00341861) | National Cancer Institute (NCI) | 1998-09-01 |
| Docetaxel in Treating Patients With Solid Tumors (NCT00003565) | Alliance for Clinical Trials in Oncology | 1998-09-01 |
| Chemotherapy in Treating Patients With Early-Stage Bladder Cancer (NCT00003129) | Eastern Cooperative Oncology Group | 1998-09-01 |
| Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00003640) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-09-01 |
| Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer (NCT00004154) | M.D. Anderson Cancer Center | 1998-07-30 |
| Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer (NCT00006034) | Intracel | 1998-06-01 |
| Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium (NCT00310011) | Wake Forest University Health Sciences | 1998-06-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435) | National Cancer Institute (NCI) | 1998-05-01 |
| Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease (NCT00026884) | National Cancer Institute (NCI) | 1998-03-12 |
| Genetic Susceptibility to Bladder Cancer (NCT00848289) | M.D. Anderson Cancer Center | 1998-02-10 |
| Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer (NCT00003342) | Memorial Sloan Kettering Cancer Center | 1997-12-01 |
| Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer (NCT00003175) | Medical Research Council | 1997-12-01 |
| Bladder Cancer Case Control Study of Arsenic in Water (NCT00011518) | National Institute of Environmental Health Sciences (NIEHS) | 1997-10-01 |
| Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer (NCT00003133) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer (NCT00003105) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer (NCT00005047) | SWOG Cancer Research Network | 1997-08-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00002914) | Eastern Cooperative Oncology Group | 1997-07-15 |
| Surgery and BCG in Treating Patients With Bladder Cancer (NCT00002990) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-03-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer (NCT00003725) | Anthra Pharmaceuticals | 1996-12-01 |
| Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer (NCT00002919) | Memorial Sloan Kettering Cancer Center | 1996-11-01 |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis (NCT00002949) | University of Chicago | 1996-07-01 |
| Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer (NCT00002684) | Memorial Sloan Kettering Cancer Center | 1995-05-01 |
| The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) (NCT01447199) | M.D. Anderson Cancer Center | 1994-09-01 |
| Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer (NCT01442519) | University of Rome Tor Vergata | 1994-01-01 |
| Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) (NCT01316874) | Endo USA Inc., a Keenova Therapeutics Company | 1993-11-01 |
| Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer (NCT00002490) | Medical Research Council | 1991-09-01 |
| Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer (NCT00002520) | Eastern Cooperative Oncology Group | 1990-12-07 |
| Molecular Analysis Of Bladder Cancer (NCT00871754) | Lahey Clinic | 1988-04-01 |
| Duke Urology Database and Specimen Bank (NCT00978991) | Duke University | 1988-01-01 |
| An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG (NCT06443944) | CG Oncology, Inc. | |